Glutamine is the preferred precursor for the neurotransmitter pool of glutamate, the major excitatory transmitter in the mammalian central nervous system. We have isolated a complementary DNA clone (designated GlnT) encoding a plasma membrane glutamine transporter from glutamatergic neurons in culture, and its properties have been examined using the T7 vaccinia system in fibroblasts. When GlnT is transfected into CV-1 cells, L-glutamine is the preferred substrate. Transport is Na ؉ -dependent and inhibited by ␣-methylaminoisobutyric acid, a specific inhibitor of neutral amino acid transport system A. Kinetic analysis of glutamine uptake by GlnT is saturable, with a Michaelis constant (K m ) of 489 ؎ 88 M at pH 7.4. Glutamine uptake mediated by GlnT is pH-sensitive with a 5-fold greater efficiency of uptake at pH 8.2 than at pH 6.6. Only the maximal velocity of transport increases without a significant change in K m . The distribution of GlnT mRNA and protein in the central nervous system is widespread and is expressed on neurons that use glutamate as their neurotransmitter. In cultured cerebellar granule cells, GlnT is expressed only on neurons and is absent from astrocytes. GlnT expression increases concomitantly with the morphologic and functional differentiation of these cells in vitro, consistent with its role of supplying glutamatergic neurons with their neurotransmitter precursor. GlnT is the first member of the system A family of neutral amino acid transporters with 11 putative membrane-spanning domains and is a potential target to modulate presynaptic glutamatergic function.
The metabolic dependence of glutamatergic neurons upon glia via the glutamate-glutamine cycle to provide the precursor for neurotransmitter glutamate is well established (1) (2) (3) (4) (5) . Upon synaptic release, glutamate is rapidly removed from the synaptic cleft by glutamate transporters that are located primarily on surrounding astroglial cells (6 -9) . There, glutamate is converted to glutamine by glutamine synthetase, an astrocytespecific enzyme (10) . To replenish the neurotransmitter pool of glutamate, an intensive glutamine flow from astrocytes to glutamatergic neurons must occur. Once glutamine is taken up into the glutamatergic neuron, phosphate-activated glutaminase converts it into glutamate (11) (12) (13) . Glutamate is then sequestered in synaptic vesicles to be made available for regulated neurosecretion (14, 15) . It has been shown in a variety of nerve cell preparations that glutamate derived from glutamine is preferentially secreted at glutamatergic synapses (16 -19) .
The major carriers for glutamine uptake within the brain are known as systems A, L, and ASC (20 -23) . Systems A and L were the first neutral amino acid systems to be described and were so named because of their preference for alanine and leucine, respectively (24) . System A is defined as a sodium-dependent, low affinity, unidirectional transporter that exhibits reduced activity at low pH. A characteristic feature of system A is the ability to transport N-methylated substrates such as the nonmetabolizable amino acid analogue ␣-(methylamino)isobutyric acid (MeAIB) . 1 This property differentiates it from systems L and ASC. Complementary cDNA clones have been isolated for several members of the system L and ASC transporter families (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . System L transporters are high affinity, sodium-independent transporters that prefer large apolar branched-chain and aromatic amino acids. They display unusual tolerance to variations in extracellular pH and are specifically inhibited by the nonmetabolizable substrate 2-aminobicyclo(2,2,1)heptane 2-carboxylic acid (BCH). System ASC transporters are sodium-dependent and transport alanine, serine, and cysteine most efficiently. They can also function over a broad pH range and, in some situations, mediate amino acid release more than uptake (35, 36) . Kinetic studies have shown that distinct transport systems exist for glutamine in neurons and astrocytes (37) (38) (39) . Uptake of glutamine by rat cerebellar granule cells, a predominantly glutamatergic nerve cell population, is primarily mediated by system A (40) .
Molecular cloning of the system A family of transporters has remained elusive. Recently, the transporter that mediates uptake of GABA and glycine into synaptic vesicles has been cloned from the nematode Caenorhabditis elegans (unc-47) and mammals (41, 42) . This vesicular transporter displays weak similarity to a family of amino acid/auxin permeases (AAAP), which are found in plants (AAP), yeast, and C. elegans (43) . In plants, five AAP homologues have been shown primarily to mediate transport of neutral amino acids across the plasma membrane (44 -46) . The function of members of the AAAP family in yeast and in C. elegans is unknown. We investigated the possibility that mammalian homologues of the AAAP family encode amino acid transporters. In particular, we sought to * This work was supported by National Institutes of Health Grant NS36936. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. identify mammalian cDNA clones that might be associated intimately with the metabolic/sequestration pathway of neurotransmitter glutamate.
Here, we reveal the amino acid sequence of GlnT, a neuronal glutamine transporter and propose an 11-transmembrane domain structure for the protein. We show by Northern analysis and in situ hydridization histochemistry the distribution of GlnT mRNA. Central nervous system and neuron-specific expression of GlnT, as well as its developmental time course in vitro, are further shown by Western blotting and by immunofluorescence of primary granule cell cultures, a good model for glutamatergic neurons. The identification of GlnT as a Na ϩ -dependent and pH-sensitive glutamine transporter on glutamatergic neurons provides a missing link in the glutamine-glutamate cycle. The role of GlnT as a physiologically important gateway for the precursor of the releasable pool of glutamate can now be studied at the molecular level.
EXPERIMENTAL PROCEDURES
Primary Cultures-Cerebellar primary cultures were prepared from 8-day postnatal Harlan Sprague-Dawley rats as described, with minor modifications (47) . Cerebella were removed from decapitated rat pups, minced, and digested with trypsin (0.25 mg/ml) for 15 min at 37°C in HEPES-buffered Lebowitz medium containing 0.3% bovine serum albumin. The cell suspension was then placed in Dulbecco's modified Eagle's medium (DMEM) with 5% fetal bovine serum, and centrifuged at 300 ϫ g at 4°C for 10 min. This treatment was followed by trituration with a Pasteur pipette in DNase I (50 g/ml) containing DMEM/5% fetal bovine serum. The cell suspension was allowed to settle for 15 min at room temperature, and the supernatant was transferred to a centrifuge tube on ice. This trituration step was repeated two more times, and the combined supernatants were centrifuged as described above. The cell pellet was resuspended in DMEM containing 10% fetal calf serum, 2 mM glutamine, and 100 g/ml penicillin/streptomycin and plated at a density of 15 or 3.75 ϫ 10 5 cells/cm 2 (neuronal and astrocytic cultures, respectively) in 65-mm-diameter plastic dishes coated with 10 g/ml polyornithine. Cells were also plated on polyornithine-coated glass 2-well chamber slides (Nunc) at 1 ϫ 10 6 /well. The medium for neuronal cultures also contained 25 mM KCl (final concentration). After 18 h, 10 M cytosine arabinoside was added to the neuronal cultures to prevent the replication of non-neuronal cells. The astrocyte culture medium was changed at day 3 in vitro and every other day afterward. The neuronal culture medium was 50% refreshed at day 7. Cerebellar neuronal cultures contained more than 95% granule cells, whereas astrocyte cultures contained more than 95% glial fibrillary acid protein (GFAP)-positive cells (47) .
Cloning of GlnT-An oligo(dT)-primed, size-selected cDNA library from cerebellar granule cells (10 days in culture) was constructed in a modified T7 promoter bearing plasmid expression vector CDM7/amp (48) . Subdivisions of the library were screened with a degenerate oligonucleotide probe against the amino acid sequence (MSVFNLSNAIMGS-GILG) of mouse EST 277610, which corresponds to the conserved putative TMD 1 of the yeast AAAP homologues (43) and region I (41% identity) of UNC-47 (41) . Southern blots of EcoRI restriction digests of plasmid prepared from overnight cultures were hybridized overnight at 45°C in a buffer containing 5ϫ SSC, 25% formamide, 1ϫ Denhardt's solution, and 200 g/ml tRNA, and the oligonucleotide probe was labeled using terminal deoxynucleotidyltransferase (Life Technologies, Inc.) and [ 32 P]dATP (NEN Life Science Products). The filters were washed in 1ϫ SSC, 0.1% SDS at 60°C. Autoradiographs were analyzed using BAS2000 phosphorimager system (Fuji Biomedical) after a 12-h exposure. The 2.4-kilobase cDNA purified was subcloned into pUC18, and overlapping fragments were sequenced in both directions with the Thermo Sequenase cycle sequencing kit (Amersham Pharmacia Biotech) according to the manufacturer's instructions.
Preparation of GlnT Antibody-The coding region for the NH 2 -terminal hydrophilic portion of GlnT (amino acids 1-63) was subcloned into the bacterial expression vector pGEX-KT, and the resulting plasmid was transfected into BL21 cells. The recombinant glutathione S-transferase fusion protein was produced and isolated using a bulk glutathione S-transferase purification module (Amersham Pharmacia Biotech) according to the manufacturer's instructions. Polyclonal antibodies were produced in rabbits by Macromolecular Resources at Colorado State University.
Northern Analysis-Poly(A) ϩ RNA was purified from different rat tissues by guanidine isothiocyanate extraction and ultracentrifugation through a cesium trifluoroacetic acid cushion followed by a single round of oligo(dT) cellulose chromatography (49) . Ten micrograms of RNA were electrophoresed through formaldehyde-agarose gels, electroblotted onto nylon membranes, and hybridized with 32 P-labeled oligonucleotide probes against 3Ј noncoding sequences (bases 1960 -2008) or coding sequences (bases 815-862) of GlnT in buffer containing 6ϫ SSPE, 50% formamide, 1ϫ Denhardt's solution, and 250 g of tRNA for 18 h at 45°C. The filters were washed in 1ϫ SSPE, 0.1% SDS at 60°C and exposed to x-ray film with an intensifying screen at Ϫ70°C for 3 days.
In Situ Hybridization-Fifteen-m sagittal fresh-frozen brain sections were hybridized at 45°C in 4ϫ SSC, 50% formamide, 1ϫ Denhardt's, 250 g/ml tRNA, 500 g/ml salmon sperm DNA (sheared and heat-denatured), and 10% dextran sulfate with 35 S-labeled oligonucleotide probe for 16 h at 37°C in a humid chamber (50) . Slides were washed in 1ϫ SSPE, 0.1% SDS at 55°C, air-dried, and exposed to BioMax MR film (Kodak) for 2 weeks. Both GlnT oligonucleotides shown to specifically label a single band on Northern blots were used, and identical results were obtained. For comparison, an oligonucleotide against the vesicular GABA/glycine transporter (bases 1852-1899) was also examined.
Immunofluorescence-Primary cerebellar cultures grown for 10 days on polyornithine-coated glass slides were fixed in cold acetone for 3 min, rinsed in PBS, blocked in 0.01% Tween 20, 2% normal goat serum, 2% bovine serum albumin in PBS for 1 h, and incubated for 3 h with a rabbit polyclonal antibody directed against GlnT and a mouse monoclonal antibody against GFAP (Roche Molecular Biochemicals) diluted 1:1500 and 1:500, respectively, in blocking buffer. The slides were then washed in PBS, incubated for 1 h in secondary antibodies coupled to Alexa-488 and Alexa-594 (anti-rabbit and anti-mouse, respectively; Molecular Probes), diluted 1:100 in blocking buffer, washed, mounted with SlowFade (Molecular Probes), and viewed under epifluorescence.
Membrane Preparations and Western Analysis-For primary cultures, cells were rinsed with PBS, harvested by scraping in PBS, centrifuged, and resuspended in PBS containing 1 mM phenylmethylsulfonyl fluoride, 5 mg/liter pepstatin, 5 mg/liter leupeptin, and 5 mg/liter aprotinin, sonicated, and centrifuged at 2000 ϫ g for 5 min. The resulting supernatants were kept frozen at Ϫ80°C until further use. Various rat tissues and brain regions were rapidly dissected following decapitation and stored frozen at Ϫ80°C. Upon thawing, the samples were homogenized (glass/glass) in PBS containing protease inhibitors, sonicated and centrifuged at 2000 ϫ g for 5 min to eliminate cell debris, and processed immediately. Five g of SDS-solubilized cell extracts or 10 g of rat tissue extracts were size-fractionated under reducing conditions on 8% acrylamide gels and electrophoretically transferred to nitrocellulose membrane using standard protocols. GlnT, synaptophysin (p38), and GFAP were detected using the respective primary antibodies, horseradish peroxidaseconjugated secondary antibodies (Sigma), and chemiluminescent reagents (Amersham Pharmacia Biotech) followed by exposure to film.
Subcellular Fractionation-The subcellular fractionation of a crude synaptosomal preparation from rat brain was performed as described by Huttner and co-workers (51) with minor modifications. Two rat cerebrums were homogenized in 30 ml of homogenization buffer (0.32 M sucrose, 10 mM HEPES-NaOH, pH 7.4, 1 mM phenylmethylsulfonyl fluoride, 5 mg/liter pepstatin, 5 mg/liter leupeptin, and 5 mg/liter aprotinin) using a glass/Teflon homogenizer (12 strokes, 900 rpm). The homogenate was centrifuged for 10 min at 800 ϫ g in a Beckman JA25.5 rotor. The pellet (P1) was saved, and the supernatant was centrifuged again for 15 min at 9,200 ϫ g. The pellet was resuspended in 20 ml of homogenization buffer and recentrifuged at 10,200 ϫ g to yield a washed synaptosomal pellet (P2). The supernatants of the last two spins were pooled (S2). The synaptosomes in P2 were resuspended in homogenization buffer (final volume 5 ml), hypo-osmotically lysed by the addition of 45 ml of ice-cold 5 mM HEPES-NaOH, pH 7.4, containing protease inhibitors, and homogenized with a glass/Teflon homogenizer (10 strokes, 900 rpm) followed by rocking at 4°C for 15 min. The lysed synaptosomes were centrifuged for 20 min at 25,000 ϫ g, and the resulting LP1 pellet was saved. The supernatant was centrifuged again for 1 h at 50,000 rpm in a Ti50.4 rotor to obtain LP2 pellets and the LS2 supernatant. The pellets were resuspended in a total of 5 ml of 25 mM sucrose and layered on top of a linear continuous sucrose gradient made from 16 ml of 50 mM sucrose and 15 ml of 800 mM sucrose. Centrifugation was performed for 150 min in a SW 28 rotor at 25,000 rpm, and the broad turbid band in the 200 -500 mM sucrose region was collected and centrifuged in a 70 Ti rotor for 2 h at 40,000 rpm. The microsomal pellet at the bottom of the sucrose gradient was saved. The protein concentrations of all fractions were determined using the Bradford protein assay (Bio-Rad) after 5ϫ dilution in PBS containing 0.1% SDS.
Transient Expression and Transport Assay-Monkey kidney fibroblasts (CV-1 cells) were plated on collagen-coated 12-well dishes (2 ϫ 10 5 cells/well) in DMEM containing 10% fetal bovine serum, penicillin (100 units/ml), streptomycin (100 mg/ml), and glutamine (4 mM). Cells were rinsed with DMEM without serum, antibiotics, or glutamine, infected with recombinant T7 vaccinia virus at 10 plaque-forming units/ cell for 30 min, and then transfected with plasmid cDNA (1 g/ml) by lipofection in the same medium (52 H]glutamine. Cells were placed in a 37°C incubator for the indicated time, and uptake was terminated with a 2.5-ml wash in 4°C buffer on ice. For kinetic and inhibition studies, as well as for ion substitutions, uptake was terminated at 2.5 or 3 min. Cells were then solubilized in 1 ml of 1% SDS, and radioactivity was measured by scintillation counting in 5 ml of EcoScint (National Diagnostics). Transport measurements were performed in duplicate and repeated at least three times using independent infection/transfections. All experimental conditions with GlnT-transfected cells had corresponding mock-transfected cells in adjacent wells. Glutamine transport mediated by the L-type system was defined as total transport minus transport in the presence of BCH, the ASC-type system-mediated process was the glutamine uptake in the presence of BCH and MeAIB, and the A-type system-mediated glutamine transport was the uptake calculated by subtracting the ASC-mediated uptake from the total Na ϩ -dependent uptake in the presence of BCH (40) .
RESULTS
Cloning and Structural Features of GlnT-Our cloning strategy began with a search of the EST data base for distant mammalian homologues of the vesicular GABA/glycine transporter. A mouse EST was obtained that displayed high sequence identity to region I of RUNC-47, a region highly conserved among amino acid permeases in the AAAP family of plants, in yeast, and in C. elegans (Fig. 1) . We screened a rat cDNA library prepared from glutamatergic neuronal cultures with an oligonucleotide corresponding to this region of the EST. A cDNA clone with an open reading frame of 1455 base pairs, predicting a highly hydrophobic protein of 485 amino acids and a molecular mass of 53,848 daltons, was obtained (Fig. 2) . Hydropathy analysis suggests 11 hydrophobic membranespanning segments (TMD). The absence of a signal sequence for membrane insertion in the NH 2 terminus suggests that it is retained in the cytoplasm leaving the short COOH terminus located extracellularly. This topologic model is slightly different from that suggested for the GABA/glycine vesicular transporter with 10 TMDs (41, 42) and is more in line with predictions made for plant and yeast AAAP members (43) . The granule cell cDNA clone has two canonical sites for N-linked glycosylation between putative TMDs 5 and 6, and unlike the GABA/glycine vesicular transporter (42) , it is glycosylated (data not shown). Consensus sequences for phosphorylation by protein kinase C occur on predicted cytoplasmic domains in the NH 2 terminus and between putative TMDs 6 and 7.
Distribution of GlnT-To provide a clue as to the functional identity of this putative transporter, we examined the distribution of its cognate mRNA and protein (Fig. 3) . In situ hybridization reveals a widespread distribution in the neurons of the brain that is distinct from the pattern observed using the vesicular GABA/glycine transporter as a probe (Fig. 3A) . In particular, neurons that use glutamate as their transmitter, such as pyramidal cells of the cerebral cortex and hippocampus as well as granule cells of the cerebellum, are labeled. By Northern analysis, the mRNA (ϳ8 kb) is found to be enriched in the brain and spinal cord, with low levels observed in the colon (Fig. 3B ). This mRNA is not observed in peripheral tissues such as lung, liver, spleen, or kidney. Brain specificity of expression was further demonstrated using antisera directed against the NH 2 terminus of the protein. On Western blots, this antibody detects a protein of approximately 55 kDa (Fig. 4B) , which is expressed in most brain areas with the highest levels seen in the cerebellum and thalamus (Fig. 3C) .
Immunochemical Detection of GlnT in Glutamatergic Neurons-We examined the expression of GlnT in primary cultures of rat cerebellar granule cells, which are a good model for glutamatergic neurons. High levels of expression are observed on neuronal cell bodies, processes, and terminals, whereas parallel astrocyte cultures are devoid of immunoreactivity (Fig.  4, A and C) . In the neuronal cultures, specific immunoreactivity increases concomitantly with the morphological differentiation of the cells (Fig. 4D) . The stimulus-coupled release of glutamate that is derived from glutamine also develops gradually and concomitantly with neuronal differentiation (47) . Together, these results are consistent with this putative transporter being important for glutamatergic neuronal function.
Subcellular Distribution of GlnT-Because the cloning of GlnT was based, in part, on the homology to a vesicular transporter, we investigated whether GlnT, also, resided on synaptic vesicles. Subcellular fractionation of synaptosomes prepared from rat cerebrum reveals that GlnT is not enriched in the purified synaptic vesicle fraction but instead follows a distribution that resembles that of syntaxin, a plasma membrane marker, more than synaptophysin, a synaptic vesicle marker (Fig. 5) . By immunofluorescence, GlnT reactivity does not appear punctate or concentrated at synaptic boutons (Fig. 4A) , a characteristic feature of synaptic vesicle localization (53) . Together, these results indicate that GlnT resides and functions at the plasma membrane.
Functional Identification of GlnT-Because several AAAP members in plants are known to transport neutral amino acids, and the protein encoded by the granule cell cDNA was selectively expressed on the plasma membrane of glutamatergic neurons, we examined whether GlnT would transport glutamine, the precursor for neurotransmitter glutamate. This cDNA was transiently expressed in fibroblasts using the vaccinia virus/bacteriophage T7 hybrid system (52) , and the cultures were incubated with [ 3 H]glutamine. The time course of GlnT-specific uptake of glutamine is shown in Fig. 6A . The total uptake of glutamine is approximately 2.5-fold greater in the transfected cells than in mock-transfected cells (Fig. 6A,  inset) . We next examined the sensitivity of uptake to BCH and MeAIB, which are selective antagonists for neutral amino acid transport systems L and A, respectively. These inhibitors do not inhibit system ASC transport. The system L and system ASC-like portions of the uptake are similar in mock and GlnTexpressing cells, whereas a system A component is observed in GlnT transfected cells only (Fig. 6A, inset) . Therefore, GlnT is a system A transporter and, unlike the endogenous neutral amino acid transport systems found in CV1 cells, it can accumulate MeAIB. To further define the characteristics of GlnT, we tested the ability of various amino acids (0.8 mM) to compete with [
14 C]MeAIB for uptake (Fig. 6B) . The L isoform of glutamine is the preferred substrate for GlnT. Asparagine, histidine, alanine, methionine, and serine are all less effective The transporter encoded by GlnT has an absolute requirement for extracellular Na ϩ ions, because choline (2% of control) and lithium (5% of control) cannot effectively substitute for sodium. Replacement of chloride with nitrate or acetate results in uptake changes of less than 11%, suggesting that anions are not involved in the glutamine uptake. A characteristic feature of GlnT is its pH sensitivity. Glutamine uptake mediated by GlnT is strongly pH-sensitive with uptake at pH 8.2 being approximately five times greater than that seen at pH 6.6 (Fig.  6C) . Transport of glutamine by GlnT, however, is not inhibited by carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP), a proton ionophore, indicating that a proton electrochemical gradient is not utilized as a driving force for uptake. Kinetic analysis of glutamine uptake by GlnT at pH 7.4 is saturable, with a Michaelis constant (K m ) of 489 Ϯ 88 M; n ϭ 4 (Fig. 6D) . The affinity of GlnT for glutamine is unchanged at pH 8.2 (K m ϭ 582 Ϯ 100 M; n ϭ 4). Instead, the maximal velocity (V max ) of transport increases significantly between pH 7.4 and 8.2 (1 Ϯ 0.26 -2.8 Ϯ 0.72 nmol/min/well, p Ͻ 0.05).
DISCUSSION
GlnT is the first member of the system A family of neutral amino acid transporters and, as a highly efficient glutamine 
FIG. 4. Expression and developmental regulation of GlnT on glutamatergic neurons in vitro.
A, double immunofluorescence labeling of acetone-fixed primary cerebellar cell cultures shows that GlnT (green) is expressed in the cell bodies and processes of granule cell neurons and not in GFAP-positive astrocytes (red). B, specificity of the GlnT antibody. Inclusion (ϩ) of the glutathione S-transferase fusion protein (20 g/ml) that was used to generate the GlnT antibody abolishes immunostaining. C, GlnT is detected in cerebellar granule cells and not astrocytes. Same samples were also probed for synaptophysin and GFAP, markers of neurons, and glia, respectively. D, GlnT expression is developmentally up-regulated in postnatal cultures (P8 -P18) of cerebellar granule cells and reaches maximal levels by day 7 (ϳP15). transport system present on glutamatergic neurons, provides a missing link in the glutamate-glutamine cycle. Because the ventricular fluid and therefore the extracellular concentration of glutamine (0.5 mM) (54) is around the K m of GlnT, this low affinity transporter on glutamatergic neurons may be a physiologically important gateway for the precursor of the neurotransmitter glutamate.
Glutamine transport by GlnT is sodium-dependent, it cannot tolerate lithium substitution for sodium, its activity is reduced at low pH, and it transports N-methylated substrates such as MeAIB. These features indicate that it is a system A transport system. Other members of the GlnT family undoubtedly exist, as system A (MeAIB-inhibitable) transport occurs in nearly all cell types, whereas GlnT expression is restricted to nervous tissue. Furthermore, system A preferentially transports short, polar, and straight-chained amino acids such as alanine, glycine, and proline, yet glutamine is a preferred substrate for GlnT. Asparagine, histidine, alanine, methionine, and serine are also effective competitors of [ 14 C]MeAIB for uptake by GlnT (IC 50 ϳ 1 mM), but these amino acids are present at one-tenth the concentration of glutamine in cerebral spinal fluid (54) and are therefore not likely substrates of GlnT in vivo. Recently, it has been shown that glutamine uptake by cerebellar granule cells in vitro is primarily mediated by system A. Interestingly, high concentrations of proline and glycine (10 mM) are required to inhibit 50% of the glutamine transport activity in these cultures (40) , consistent with the inability of these amino acids to interact with GlnT. System A is not a simple single-transport system, as variants emerge in certain cell lines (55) . We have isolated a related cDNA clone that displays a widespread distribution and exhibits broad substrate specificity similar to the "classic" alanine-preferring system A transport. 2 Thus, the system A family of transporters may be expected to express different substrate preferences and display unique tissue specificity. No significant homology is found between GlnT and the families of neutral amino acid transport systems L and ASC (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . GlnT is distantly related to the amino acid permease family found in plants, yeast, and C. elegans as well as to the vesicular GABA/glycine transporter (41) (42) (43) . Active transport of neutral amino acids by the plant permeases is via an H ϩ -symport mechanism, whereas the vesicular GABA/glycine transporter mediates H ϩ -exchange (41, 44 -46, 56) . A characteristic feature of GlnT is its pH sensitivity, as the efficiency of glutamine transport greatly increases at alkaline pH. Although it is clear that the driving force for GlnT-mediated transport of glutamine is the transmembrane Na ϩ gradient, this pH-dependent V max change may indicate that the mechanism also involves counter-transport of H ϩ ions. Interestingly, glutamate clearance from the synaptic region by glia is powered by the inward movement of H ϩ and outward K ϩ and OH Ϫ transport FIG. 5 . Localization of GlnT by subcellular fractionation. The following rat brain fractions were analyzed: brain homogenate (TO-TAL); low-speed pellet (P1), washed synaptosomes (P2), supernatant of synaptosomal fraction (S2), low-speed pellet of lysed synaptosomes (LP1), high-speed pellet from lysed synaptosomes (LP2), synaptosomal cytosol (LS2), synaptic vesicles (SV) purified from LP2 by continuous sucrose density gradient fractionation, and the microsomal fraction (microsome) of the lysed synaptosomes. Five g (top) and 1 g (bottom) of protein from each fraction were immunoblotted with antibodies to GlnT, synaptobrevin (p65), synaptophysin (p38), and syntaxin. GlnT does not co-purify with the vesicular markers p38 and p65 but rather with the plasma membrane marker synataxin. (57). This shift of extrasynaptic pH toward more alkaline levels could facilitate the transport of glutamine into the glutamatergic neuron. Indeed, alteration of systemic or synaptic pH may have a significant role in the regulation of various processes of the glial/ neuronal metabolism of glutamine and glutamate (58 -60) . In contrast to GlnT, a system ASC transporter (ASCT2), is selectively expressed in rat astroglia-rich primary cultures but not in neuron-rich primary cultures (36) . ASCT2 also may play an essential part of the glutamate-glutamine cycle in the brain by mediating glutamine release from astrocytes. Although ASC transporters display high affinity for glutamine uptake (K m ϳ 70 M), they are highly trans-stimulated, suggesting an exchanger mechanism of transport. That is, in the presence of unlabeled neutral amino acids, rapid efflux of glutamine occurs from glia preloaded with radiolabeled glutamine. Interestingly, at low pH even glutamate becomes a substrate promoting the release of glutamine from the astrocyte. Such extrasynaptic pH changes might occur during exocytotic release of glutamate because of the acidic content of glutamatergic synaptic vesicles (61) .
Glutamine may also serve as a precursor for GABA in inhibitory neurons in the brain following decarboxylation of glutamate by glutamic acid decarboxylase. The distribution of GlnT mRNA differs significantly from that of the vesicular inhibitory amino acid transporter, a marker for GABAergic neurons in the brain. Our preliminary evidence suggests, however, that GlnT may be expressed in Purkinje neurons, known to use GABA as a neurotransmitter. Primary glutamatergic neuronal cultures exhibit more efficient glutamine transport activity than predominantly GABAergic cortical neurons (40) . Because the relative loss of GABA from neurons to astrocytes is modest (62, 63) , a more efficient transport system for glutamine may therefore be required for glutamatergic neurons.
System A is a major target of endocrine and oncogenic regulation and also is significantly up-regulated as an adaptation to cellular depletion in its amino acid substrates (20, 21, 64) . Presently, little is known regarding regulation of glutamine transport by glutamatergic neurons. Further studies of GlnT function and regulation will undoubtedly bring new insight into the functional role of glutamine in glutamate homeostasis and in modulating presynaptic glutamatergic function and hence, excitability.
